US Stock MarketDetailed Quotes

AKRO Akero Therapeutics

Watchlist
  • 35.280
  • +2.540+7.76%
Close Nov 6 16:00 ET
  • 32.620
  • -2.660-7.54%
Post 20:01 ET
2.45BMarket Cap-10255P/E (TTM)

Akero Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Akero Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2024/Q4 -- / 0.000 --
-- 2024/Q3 -- / 0.000 --
-- 2024/Q2 0.000 / 0.000 --
-- 2024/Q1 0.000 / 0.000 --
-- 2023/Q4 0.000 / 0.000 --
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q3-- / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--

Unlock Free Earnings Estimates

Akero Therapeutics Earnings Reports

  • Akero Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 9 19:32

  • Akero Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 10 19:34

  • Akero Therapeutics | 10-K: FY2023 Annual Report

    Feb 29 20:33

  • Akero Therapeutics | 10-Q: Q3 2023 Earnings Report

    Nov 13, 2023 20:33

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 31, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data